ondansetron has been researched along with peptide yy in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (33.33) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ciociola, A; Haddad, A; Miller, LJ; Phillips, SF; Talley, NJ; Twomey, C; Zinsmeister, AR | 1 |
| Perry, MR; Rhee, J; Smith, WL | 1 |
| Chen, JH; Lin, HC; Neevel, C | 1 |
1 trial(s) available for ondansetron and peptide yy
| Article | Year |
|---|---|
Effect of selective 5HT3 antagonist (GR 38032F) on small intestinal transit and release of gastrointestinal peptides.
Topics: Adult; Cecum; Female; Gastrointestinal Hormones; Gastrointestinal Motility; Humans; Imidazoles; Intestine, Small; Male; Ondansetron; Peptide YY; Peptides; Receptors, Serotonin; Secretory Rate | 1989 |
2 other study(ies) available for ondansetron and peptide yy
| Article | Year |
|---|---|
Plasma levels of peptide YY correlate with cisplatin-induced emesis in dogs.
Topics: Animals; Cisplatin; Dogs; Drug Interactions; Drug Therapy, Combination; Female; Granisetron; Immunoenzyme Techniques; Ondansetron; Peptide YY; Peptides; Radioimmunoassay; Random Allocation; Serotonin; Vomiting | 1994 |
Slowing intestinal transit by PYY depends on serotonergic and opioid pathways.
Topics: Animals; Depression, Chemical; Dogs; Gastrointestinal Transit; Naloxone; Narcotic Antagonists; Ondansetron; Peptide YY; Receptors, Opioid; Serotonin; Serotonin Antagonists; Signal Transduction; Synaptic Transmission | 2004 |